$MRNS Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in MARINUS PHARMACEUTICALS INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in MARINUS PHARMACEUTICALS INC. Get notifications about new insider transactions in MARINUS PHARMACEUTICALS INC for free.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Apr 13 2021 | MRNS | MARINUS PHARMACEUT ... | Pfanstiel Steven | CFO | Option Exercise | A | 13.99 | 220,000 | 3,077,800 | 220,000 | |
Mar 24 2021 | MRNS | MARINUS PHARMACEUT ... | Nochur Sara | Director | Option Exercise | A | 16.42 | 33,000 | 541,860 | 33,000 | |
Mar 16 2021 | MRNS | MARINUS PHARMACEUT ... | VITULLO NICOLE | Director | Buy | J | 0.00 | 2,717 | 0 | 3,692 | 975 to 3.7 K (+278.67 %) |
Mar 16 2021 | MRNS | MARINUS PHARMACEUT ... | VITULLO NICOLE | Director | Sell | J | 0.00 | 11,612 | 0 | 0 | 11.6 K to 0 (-100.00 %) |
Mar 16 2021 | MRNS | MARINUS PHARMACEUT ... | VITULLO NICOLE | Director | Sell | J | 0.00 | 6,192 | 0 | 0 | 6.2 K to 0 (-100.00 %) |
Mar 16 2021 | MRNS | MARINUS PHARMACEUT ... | VITULLO NICOLE | Director | Sell | S | 15.87 | 4,250 | 67,448 | 0 | 4.3 K to 0 (-100.00 %) |
Mar 16 2021 | MRNS | MARINUS PHARMACEUT ... | VITULLO NICOLE | Director | Buy | J | 0.00 | 6,192 | 0 | 6,192 | 0 to 6.2 K |
Mar 16 2021 | MRNS | MARINUS PHARMACEUT ... | VITULLO NICOLE | Director | Sell | J | 0.00 | 619,221 | 0 | 0 | 619.2 K to 0 (-100.00 %) |
Jan 20 2021 | MRNS | MARINUS PHARMACEUT ... | VITULLO NICOLE | Director | Option Exercise | A | 12.60 | 16,500 | 207,900 | 16,500 | |
Jan 19 2021 | MRNS | MARINUS PHARMACEUT ... | DOUGHERTY MICHAEL R | Director | Option Exercise | A | 12.60 | 16,500 | 207,900 | 16,500 | |
Jan 19 2021 | MRNS | MARINUS PHARMACEUT ... | Carrazana Enrique J. | Director | Option Exercise | A | 12.60 | 16,500 | 207,900 | 16,500 | |
Jan 19 2021 | MRNS | MARINUS PHARMACEUT ... | Braunstein Scott | Chief Executive Off ... | Option Exercise | A | 12.60 | 290,000 | 3,654,000 | 290,000 | |
Jan 19 2021 | MRNS | MARINUS PHARMACEUT ... | Austin Charles | Director | Option Exercise | A | 12.60 | 16,500 | 207,900 | 16,500 | |
Jan 19 2021 | MRNS | MARINUS PHARMACEUT ... | Ezickson Elan | Director | Option Exercise | A | 12.60 | 16,500 | 207,900 | 16,500 | |
Jan 19 2021 | MRNS | MARINUS PHARMACEUT ... | Fischer Seth H. Z. | Director | Option Exercise | A | 12.60 | 16,500 | 207,900 | 16,500 | |
Jan 19 2021 | MRNS | MARINUS PHARMACEUT ... | Hulihan Joseph | Chief Medical Offic ... | Option Exercise | A | 12.60 | 115,000 | 1,449,000 | 115,000 | |
Jan 19 2021 | MRNS | MARINUS PHARMACEUT ... | MANNING MARTHA E | VP Gen Counsel and ... | Option Exercise | A | 12.60 | 57,500 | 724,500 | 57,500 | |
Jan 19 2021 | MRNS | MARINUS PHARMACEUT ... | MAYLEBEN TIMOTHY M | Director | Option Exercise | A | 12.60 | 16,500 | 207,900 | 16,500 | |
Aug 04 2020 | MRNS | MARINUS PHARMACEUT ... | Austin Charles | Director | Option Exercise | A | 1.59 | 100,000 | 159,000 | 100,000 | |
Jun 17 2020 | MRNS | MARINUS PHARMACEUT ... | MANNING MARTHA E | VP, Gen. Counsel & ... | Option Exercise | A | 2.52 | 300,000 | 756,000 | 300,000 | |
Feb 03 2020 | MRNS | MARINUS PHARMACEUT ... | Smith Edward F | CFO | Sell | S | 2.05 | 2,380 | 4,879 | 17,717 | 20.1 K to 17.7 K (-11.84 %) |
Jan 10 2020 | MRNS | MARINUS PHARMACEUT ... | Braunstein Scott | Chief Executive Off ... | Option Exercise | A | 2.07 | 1,800,000 | 3,726,000 | 1,800,000 | |
Jan 10 2020 | MRNS | MARINUS PHARMACEUT ... | Smith Edward F | CFO | Option Exercise | A | 2.07 | 765,000 | 1,583,550 | 765,000 | |
Jan 10 2020 | MRNS | MARINUS PHARMACEUT ... | MAYLEBEN TIMOTHY M | Director | Option Exercise | A | 2.07 | 100,000 | 207,000 | 100,000 | |
Jan 10 2020 | MRNS | MARINUS PHARMACEUT ... | Fischer Seth H. Z. | Director | Option Exercise | A | 2.07 | 100,000 | 207,000 | 100,000 | |
Jan 10 2020 | MRNS | MARINUS PHARMACEUT ... | Carrazana Enrique J. | Director | Option Exercise | A | 2.07 | 100,000 | 207,000 | 100,000 | |
Jan 10 2020 | MRNS | MARINUS PHARMACEUT ... | DOUGHERTY MICHAEL R | Director | Option Exercise | A | 2.07 | 100,000 | 207,000 | 100,000 | |
Jan 10 2020 | MRNS | MARINUS PHARMACEUT ... | Hulihan Joseph | Chief Medical Offic ... | Option Exercise | A | 2.07 | 405,000 | 838,350 | 405,000 | |
Jan 10 2020 | MRNS | MARINUS PHARMACEUT ... | VITULLO NICOLE | Director | Option Exercise | A | 2.07 | 100,000 | 207,000 | 100,000 | |
Dec 13 2019 | MRNS | MARINUS PHARMACEUT ... | Braunstein Scott | Chief Executive Off ... | Buy | P | 1.25 | 100,000 | 125,000 | 100,000 | 0 to 100 K |
Dec 13 2019 | MRNS | MARINUS PHARMACEUT ... | Ezickson Elan | Director | Option Exercise | A | 1.78 | 100,000 | 178,000 | 100,000 | |
Aug 23 2019 | MRNS | MARINUS PHARMACEUT ... | Lorianne Masuoka K. | Chief Medical Offic ... | Option Exercise | A | 1.12 | 60,000 | 67,200 | 60,000 | |
Aug 23 2019 | MRNS | MARINUS PHARMACEUT ... | Smith Edward F | CFO | Option Exercise | A | 1.12 | 60,000 | 67,200 | 60,000 | |
Aug 08 2019 | MRNS | MARINUS PHARMACEUT ... | Braunstein Scott | Executive Chairman | Option Exercise | A | 1.07 | 1,000,000 | 1,070,000 | 1,000,000 | |
May 20 2019 | MRNS | MARINUS PHARMACEUT ... | Smith Edward F | CFO | Sell | S | 5.03 | 24,211 | 121,781 | 20,097 | 44.3 K to 20.1 K (-54.64 %) |
Mar 20 2019 | MRNS | MARINUS PHARMACEUT ... | Cashman Christopher Michael | CEO | Option Exercise | M | 1.04 | 31,662 | 32,928 | 0 | |
Mar 20 2019 | MRNS | MARINUS PHARMACEUT ... | Cashman Christopher Michael | CEO | Buy | M | 1.04 | 31,662 | 32,928 | 271,423 | 239.8 K to 271.4 K (+13.21 %) |
Feb 28 2019 | MRNS | MARINUS PHARMACEUT ... | Smith Edward F | CFO | Option Exercise | A | 3.96 | 200,000 | 792,000 | 200,000 | |
Feb 28 2019 | MRNS | MARINUS PHARMACEUT ... | Lorianne Masuoka K. | Chief Medical Offic ... | Option Exercise | A | 3.96 | 200,000 | 792,000 | 200,000 | |
Feb 28 2019 | MRNS | MARINUS PHARMACEUT ... | DOUGHERTY MICHAEL R | Director | Option Exercise | A | 3.96 | 35,000 | 138,600 | 35,000 | |
Feb 28 2019 | MRNS | MARINUS PHARMACEUT ... | Fischer Seth H. Z. | Director | Option Exercise | A | 3.96 | 35,000 | 138,600 | 35,000 | |
Feb 28 2019 | MRNS | MARINUS PHARMACEUT ... | MAYLEBEN TIMOTHY M | Director | Option Exercise | A | 3.96 | 35,000 | 138,600 | 35,000 | |
Feb 28 2019 | MRNS | MARINUS PHARMACEUT ... | Braunstein Scott | Executive Chairman | Option Exercise | A | 3.96 | 240,000 | 950,400 | 240,000 | |
Feb 28 2019 | MRNS | MARINUS PHARMACEUT ... | Carrazana Enrique J. | Director | Option Exercise | A | 3.96 | 65,000 | 257,400 | 65,000 | |
Feb 28 2019 | MRNS | MARINUS PHARMACEUT ... | VITULLO NICOLE | Director | Option Exercise | A | 3.96 | 35,000 | 138,600 | 35,000 | |
Jan 30 2019 | MRNS | MARINUS PHARMACEUT ... | Cashman Christopher Michael | CEO | Sell | S | 3.13 | 8,142 | 25,484 | 239,761 | 247.9 K to 239.8 K (-3.28 %) |
Jan 30 2019 | MRNS | MARINUS PHARMACEUT ... | Smith Edward F | CFO | Sell | S | 3.06 | 2,492 | 7,626 | 44,308 | 46.8 K to 44.3 K (-5.32 %) |
Jan 29 2018 | MRNS | MARINUS PHARMACEUT ... | Smith Edward F | CFO | Sell | S | 7.91 | 3,000 | 23,730 | 49,800 | 52.8 K to 49.8 K (-5.68 %) |
Jan 24 2018 | MRNS | MARINUS PHARMACEUT ... | VITULLO NICOLE | Director | Buy | J | 0.00 | 2,250 | 0 | 46,450 | 44.2 K to 46.5 K (+5.09 %) |
Jan 24 2018 | MRNS | MARINUS PHARMACEUT ... | VITULLO NICOLE | Director | Sell | J | 0.00 | 2,250 | 0 | 3,900 | 6.2 K to 3.9 K (-36.59 %) |
Jan 22 2018 | MRNS | MARINUS PHARMACEUT ... | Cashman Christopher Michael | CEO | Sell | S | 6.28 | 9,566 | 60,074 | 247,903 | 257.5 K to 247.9 K (-3.72 %) |
Dec 19 2017 | MRNS | MARINUS PHARMACEUT ... | Bain Capital Life Sciences Inv ... | 10% Owner | Sell | S | 7.11 | 55,229 | 392,430 | 3,977,453 | 4 M to 4 M (-1.37 %) |
Dec 19 2017 | MRNS | MARINUS PHARMACEUT ... | Bain Capital Life Sciences Inv ... | 10% Owner | Sell | S | 7.62 | 94,771 | 722,240 | 4,032,682 | 4.1 M to 4 M (-2.30 %) |
Dec 19 2017 | MRNS | MARINUS PHARMACEUT ... | Bain Capital Life Sciences Inv ... | 10% Owner | Sell | S | 7.50 | 300,000 | 2,251,440 | 4,127,453 | 4.4 M to 4.1 M (-6.78 %) |
Dec 19 2017 | MRNS | MARINUS PHARMACEUT ... | Bain Capital Life Sciences Inv ... | 10% Owner | Sell | S | 8.64 | 102,882 | 888,489 | 4,427,453 | 4.5 M to 4.4 M (-2.27 %) |
Dec 19 2017 | MRNS | MARINUS PHARMACEUT ... | Bain Capital Life Sciences Inv ... | 10% Owner | Sell | S | 8.02 | 719,665 | 5,770,202 | 4,530,335 | 5.3 M to 4.5 M (-13.71 %) |
Dec 08 2017 | MRNS | MARINUS PHARMACEUT ... | VITULLO NICOLE | Director | Option Exercise | A | 6.19 | 35,000 | 216,650 | 35,000 | |
Dec 08 2017 | MRNS | MARINUS PHARMACEUT ... | MAYLEBEN TIMOTHY M | Director | Option Exercise | A | 6.19 | 35,000 | 216,650 | 35,000 | |
Dec 08 2017 | MRNS | MARINUS PHARMACEUT ... | Lorianne Masuoka K. | Chief Medical Offic ... | Option Exercise | A | 6.19 | 150,000 | 928,500 | 150,000 | |
Dec 08 2017 | MRNS | MARINUS PHARMACEUT ... | Fischer Seth H. Z. | Director | Option Exercise | A | 6.19 | 35,000 | 216,650 | 35,000 | |
Dec 08 2017 | MRNS | MARINUS PHARMACEUT ... | DOUGHERTY MICHAEL R | Director | Option Exercise | A | 6.19 | 35,000 | 216,650 | 35,000 | |
Dec 08 2017 | MRNS | MARINUS PHARMACEUT ... | Cashman Christopher Michael | CEO | Option Exercise | A | 6.19 | 500,000 | 3,095,000 | 500,000 | |
Dec 08 2017 | MRNS | MARINUS PHARMACEUT ... | Carrazana Enrique J. | Director | Option Exercise | A | 6.19 | 35,000 | 216,650 | 35,000 | |
Dec 08 2017 | MRNS | MARINUS PHARMACEUT ... | Smith Edward F | CFO | Option Exercise | A | 6.19 | 200,000 | 1,238,000 | 200,000 | |
Sep 11 2017 | MRNS | MARINUS PHARMACEUT ... | VITULLO NICOLE | Director | Buy | J | 0.00 | 1,650 | 0 | 44,200 | 42.6 K to 44.2 K (+3.88 %) |
Sep 11 2017 | MRNS | MARINUS PHARMACEUT ... | VITULLO NICOLE | Director | Sell | J | 0.00 | 1,650 | 0 | 6,150 | 7.8 K to 6.2 K (-21.15 %) |
Jan 19 2017 | MRNS | MARINUS PHARMACEUT ... | Smith Edward F | CFO | Option Exercise | A | 0.00 | 25,200 | 0 | 25,200 | |
Jan 19 2017 | MRNS | MARINUS PHARMACEUT ... | Smith Edward F | CFO | Option Exercise | A | 1.21 | 58,800 | 71,148 | 58,800 | |
Jan 19 2017 | MRNS | MARINUS PHARMACEUT ... | Shepard Jay | Director | Option Exercise | A | 0.00 | 4,500 | 0 | 4,500 | |
Jan 19 2017 | MRNS | MARINUS PHARMACEUT ... | Shepard Jay | Director | Option Exercise | A | 1.21 | 10,500 | 12,705 | 10,500 | |
Jan 19 2017 | MRNS | MARINUS PHARMACEUT ... | MAYLEBEN TIMOTHY M | Director | Option Exercise | A | 0.00 | 4,500 | 0 | 4,500 | |
Jan 19 2017 | MRNS | MARINUS PHARMACEUT ... | MAYLEBEN TIMOTHY M | Director | Option Exercise | A | 1.21 | 10,500 | 12,705 | 10,500 | |
Jan 19 2017 | MRNS | MARINUS PHARMACEUT ... | Fischer Seth H. Z. | Director | Option Exercise | A | 0.00 | 4,500 | 0 | 4,500 | |
Jan 19 2017 | MRNS | MARINUS PHARMACEUT ... | Fischer Seth H. Z. | Director | Option Exercise | A | 1.21 | 10,500 | 12,705 | 10,500 | |
Jan 19 2017 | MRNS | MARINUS PHARMACEUT ... | Cashman Christopher Michael | Chairman and CEO | Option Exercise | A | 0.00 | 60,600 | 0 | 60,600 | |
Jan 19 2017 | MRNS | MARINUS PHARMACEUT ... | Cashman Christopher Michael | Chairman and CEO | Option Exercise | A | 1.21 | 141,400 | 171,094 | 141,400 | |
Jan 19 2017 | MRNS | MARINUS PHARMACEUT ... | Carrazana Enrique J. | Director | Option Exercise | A | 0.00 | 28,500 | 0 | 28,500 | |
Jan 19 2017 | MRNS | MARINUS PHARMACEUT ... | Carrazana Enrique J. | Director | Option Exercise | A | 1.21 | 66,500 | 80,465 | 66,500 | |
Jan 19 2017 | MRNS | MARINUS PHARMACEUT ... | VITULLO NICOLE | Director | Option Exercise | A | 1.21 | 10,500 | 12,705 | 10,500 | |
Jan 19 2017 | MRNS | MARINUS PHARMACEUT ... | VITULLO NICOLE | Director | Grant | A | 0.00 | 4,500 | 0 | 7,800 | 3.3 K to 7.8 K (+136.36 %) |
Oct 24 2016 | MRNS | MARINUS PHARMACEUT ... | Mehra Anand | 10% Owner | Sell | S | 1.39 | 12,528 | 17,401 | 15,470 | 28 K to 15.5 K (-44.75 %) |
Oct 24 2016 | MRNS | MARINUS PHARMACEUT ... | Mehra Anand | 10% Owner | Sell | S | 1.39 | 13,367 | 18,567 | 224,845 | 238.2 K to 224.8 K (-5.61 %) |
Oct 24 2016 | MRNS | MARINUS PHARMACEUT ... | Mehra Anand | 10% Owner | Sell | S | 1.39 | 724,788 | 1,006,731 | 1,134,851 | 1.9 M to 1.1 M (-38.97 %) |
Aug 09 2016 | MRNS | MARINUS PHARMACEUT ... | Canaan VII LP | 10% Owner | Sell | S | 1.50 | 19,950 | 29,925 | 1,850,783 | 1.9 M to 1.9 M (-1.07 %) |
Aug 09 2016 | MRNS | MARINUS PHARMACEUT ... | Canaan VII LP | 10% Owner | Sell | S | 1.50 | 129,204 | 193,806 | 1,870,733 | 2 M to 1.9 M (-6.46 %) |
Aug 05 2016 | MRNS | MARINUS PHARMACEUT ... | Mehra Anand | Director | Option Exercise | A | 0.00 | 3,300 | 0 | 3,300 | |
Aug 05 2016 | MRNS | MARINUS PHARMACEUT ... | Mehra Anand | Director | Option Exercise | A | 1.50 | 7,700 | 11,550 | 7,700 | |
Aug 05 2016 | MRNS | MARINUS PHARMACEUT ... | Shepard Jay | Director | Option Exercise | A | 0.00 | 3,300 | 0 | 3,300 | |
Aug 05 2016 | MRNS | MARINUS PHARMACEUT ... | Shepard Jay | Director | Option Exercise | A | 1.50 | 7,700 | 11,550 | 7,700 | |
Aug 05 2016 | MRNS | MARINUS PHARMACEUT ... | Patroneva Albena | Chief Medical Offic ... | Option Exercise | A | 0.00 | 20,700 | 0 | 20,700 | |
Aug 05 2016 | MRNS | MARINUS PHARMACEUT ... | Patroneva Albena | Chief Medical Offic ... | Option Exercise | A | 1.50 | 48,300 | 72,450 | 48,300 | |
Aug 05 2016 | MRNS | MARINUS PHARMACEUT ... | MAYLEBEN TIMOTHY M | Director | Option Exercise | A | 0.00 | 3,300 | 0 | 3,300 | |
Aug 05 2016 | MRNS | MARINUS PHARMACEUT ... | MAYLEBEN TIMOTHY M | Director | Option Exercise | A | 1.50 | 7,700 | 11,550 | 7,700 | |
Aug 05 2016 | MRNS | MARINUS PHARMACEUT ... | Cashman Christopher Michael | Chairman and CEO | Option Exercise | A | 0.00 | 56,100 | 0 | 56,100 | |
Aug 05 2016 | MRNS | MARINUS PHARMACEUT ... | Cashman Christopher Michael | Chairman and CEO | Option Exercise | A | 1.50 | 130,900 | 196,350 | 130,900 | |
Aug 05 2016 | MRNS | MARINUS PHARMACEUT ... | Carrazana Enrique J. | Director | Option Exercise | A | 0.00 | 3,300 | 0 | 3,300 | |
Aug 05 2016 | MRNS | MARINUS PHARMACEUT ... | Carrazana Enrique J. | Director | Option Exercise | A | 1.50 | 7,700 | 11,550 | 7,700 | |
Aug 05 2016 | MRNS | MARINUS PHARMACEUT ... | Smith Edward F | CFO | Option Exercise | A | 0.00 | 24,600 | 0 | 24,600 | |
Aug 05 2016 | MRNS | MARINUS PHARMACEUT ... | Smith Edward F | CFO | Option Exercise | A | 1.50 | 57,400 | 86,100 | 57,400 | |
Aug 05 2016 | MRNS | MARINUS PHARMACEUT ... | VITULLO NICOLE | Director | Option Exercise | A | 1.50 | 7,700 | 11,550 | 7,700 | |
Aug 05 2016 | MRNS | MARINUS PHARMACEUT ... | VITULLO NICOLE | Director | Grant | A | 0.00 | 3,300 | 0 | 3,300 | 0 to 3.3 K |
Aug 05 2016 | MRNS | MARINUS PHARMACEUT ... | Canaan VII LP | 10% Owner | Sell | S | 1.50 | 3,329 | 4,994 | 1,999,937 | 2 M to 2 M (-0.17 %) |
Aug 05 2016 | MRNS | MARINUS PHARMACEUT ... | Canaan VII LP | 10% Owner | Sell | S | 1.50 | 142,254 | 213,381 | 2,003,266 | 2.1 M to 2 M (-6.63 %) |
Aug 02 2016 | MRNS | MARINUS PHARMACEUT ... | Canaan VII LP | 10% Owner | Sell | S | 1.71 | 24,540 | 41,963 | 2,145,520 | 2.2 M to 2.1 M (-1.13 %) |
Jul 27 2016 | MRNS | MARINUS PHARMACEUT ... | Canaan VII LP | 10% Owner | Sell | S | 1.80 | 209 | 376 | 2,170,060 | 2.2 M to 2.2 M (-0.01 %) |
Jul 27 2016 | MRNS | MARINUS PHARMACEUT ... | Canaan VII LP | 10% Owner | Sell | S | 1.81 | 20,380 | 36,888 | 2,170,269 | 2.2 M to 2.2 M (-0.93 %) |
Jul 26 2016 | MRNS | MARINUS PHARMACEUT ... | Canaan VII LP | 10% Owner | Sell | S | 1.86 | 137,617 | 255,968 | 2,190,649 | 2.3 M to 2.2 M (-5.91 %) |
Jul 26 2016 | MRNS | MARINUS PHARMACEUT ... | Canaan VII LP | 10% Owner | Sell | S | 1.94 | 133,133 | 258,278 | 2,328,266 | 2.5 M to 2.3 M (-5.41 %) |
Feb 11 2016 | MRNS | MARINUS PHARMACEUT ... | Cashman Christopher Michael | President and CEO | Option Exercise | M | 1.04 | 24,684 | 25,671 | 31,662 | |
Feb 11 2016 | MRNS | MARINUS PHARMACEUT ... | Cashman Christopher Michael | President and CEO | Buy | M | 1.04 | 24,684 | 25,671 | 140,769 | 116.1 K to 140.8 K (+21.26 %) |
Feb 11 2016 | MRNS | MARINUS PHARMACEUT ... | Cashman Christopher Michael | President and CEO | Buy | P | 5.61 | 3,561 | 19,977 | 116,085 | 112.5 K to 116.1 K (+3.16 %) |
Feb 10 2016 | MRNS | MARINUS PHARMACEUT ... | Carrazana Enrique J. | Director | Option Exercise | A | 5.63 | 25,000 | 140,750 | 25,000 | |
Sep 28 2015 | MRNS | MARINUS PHARMACEUT ... | Bloch Stephen M | Director | Option Exercise | M | 1.04 | 27,035 | 28,116 | 0 | |
Sep 28 2015 | MRNS | MARINUS PHARMACEUT ... | Bloch Stephen M | Director | Option Exercise | M | 1.04 | 12,515 | 13,016 | 0 | |
Sep 28 2015 | MRNS | MARINUS PHARMACEUT ... | Bloch Stephen M | Director | Option Exercise | A | 12.98 | 6,300 | 81,774 | 6,300 | |
Sep 28 2015 | MRNS | MARINUS PHARMACEUT ... | Bloch Stephen M | Director | Buy | M | 1.04 | 27,035 | 28,116 | 39,550 | 12.5 K to 39.6 K (+216.02 %) |
Sep 28 2015 | MRNS | MARINUS PHARMACEUT ... | Bloch Stephen M | Director | Buy | M | 1.04 | 12,515 | 13,016 | 12,515 | 0 to 12.5 K |
Jul 22 2015 | MRNS | MARINUS PHARMACEUT ... | Mehra Anand | Director | Option Exercise | A | 14.30 | 6,300 | 90,090 | 6,300 | |
Jul 22 2015 | MRNS | MARINUS PHARMACEUT ... | VITULLO NICOLE | Director | Option Exercise | A | 14.30 | 6,300 | 90,090 | 6,300 | |
Jul 22 2015 | MRNS | MARINUS PHARMACEUT ... | Cashman Christopher Michael | President and CEO | Option Exercise | A | 14.30 | 160,000 | 2,288,000 | 160,000 | |
Jul 22 2015 | MRNS | MARINUS PHARMACEUT ... | Patroneva Albena | Chief Medical Offic ... | Option Exercise | A | 14.30 | 50,000 | 715,000 | 50,000 | |
Jul 22 2015 | MRNS | MARINUS PHARMACEUT ... | Smith Edward F | CFO | Option Exercise | A | 14.30 | 70,000 | 1,001,000 | 70,000 | |
Jul 22 2015 | MRNS | MARINUS PHARMACEUT ... | Carrazana Enrique J. | Director | Option Exercise | A | 14.30 | 6,300 | 90,090 | 6,300 | |
Jul 22 2015 | MRNS | MARINUS PHARMACEUT ... | MAYLEBEN TIMOTHY M | Director | Option Exercise | A | 14.30 | 6,300 | 90,090 | 6,300 | |
Jul 22 2015 | MRNS | MARINUS PHARMACEUT ... | Shepard Jay | Director | Option Exercise | A | 14.30 | 6,300 | 90,090 | 6,300 | |
Jul 17 2015 | MRNS | MARINUS PHARMACEUT ... | MAYLEBEN TIMOTHY M | Director | Option Exercise | M | 1.04 | 27,035 | 28,116 | 0 | |
Jul 17 2015 | MRNS | MARINUS PHARMACEUT ... | MAYLEBEN TIMOTHY M | Director | Option Exercise | M | 1.04 | 15,515 | 16,136 | 0 | |
Jul 17 2015 | MRNS | MARINUS PHARMACEUT ... | MAYLEBEN TIMOTHY M | Director | Buy | M | 1.04 | 27,035 | 28,116 | 42,550 | 15.5 K to 42.6 K (+174.25 %) |
Jul 17 2015 | MRNS | MARINUS PHARMACEUT ... | MAYLEBEN TIMOTHY M | Director | Buy | M | 1.04 | 15,515 | 16,136 | 15,515 | 0 to 15.5 K |
Jul 02 2015 | MRNS | MARINUS PHARMACEUT ... | Cashman Christopher Michael | President and CEO | Option Exercise | M | 1.04 | 14,086 | 14,649 | 56,346 | |
Jul 02 2015 | MRNS | MARINUS PHARMACEUT ... | Cashman Christopher Michael | President and CEO | Buy | M | 1.04 | 14,086 | 14,649 | 112,524 | 98.4 K to 112.5 K (+14.31 %) |
Jun 11 2015 | MRNS | MARINUS PHARMACEUT ... | Bloch Stephen M | Director | Option Exercise | M | 1.04 | 3,000 | 3,120 | 12,515 | |
Jun 11 2015 | MRNS | MARINUS PHARMACEUT ... | Bloch Stephen M | Director | Gift | G | 0.00 | 3,000 | 0 | 0 | 3 K to 0 (-100.00 %) |
Jun 11 2015 | MRNS | MARINUS PHARMACEUT ... | Bloch Stephen M | Director | Buy | M | 1.04 | 3,000 | 3,120 | 3,000 | 0 to 3 K |
Apr 23 2015 | MRNS | MARINUS PHARMACEUT ... | Farfel Gail M | Chief Clinical Dev ... | Option Exercise | M | 1.04 | 30,000 | 31,200 | 8,462 | |
Apr 23 2015 | MRNS | MARINUS PHARMACEUT ... | Farfel Gail M | Chief Clinical Dev ... | Sell | S | 9.48 | 30,000 | 284,511 | 0 | 30 K to 0 (-100.00 %) |
Apr 23 2015 | MRNS | MARINUS PHARMACEUT ... | Farfel Gail M | Chief Clinical Dev ... | Buy | M | 1.04 | 30,000 | 31,200 | 30,000 | 0 to 30 K |
Mar 10 2015 | MRNS | MARINUS PHARMACEUT ... | Cashman Christopher Michael | PRESIDENT AND CEO | Option Exercise | M | 1.04 | 17,608 | 18,312 | 70,432 | |
Mar 10 2015 | MRNS | MARINUS PHARMACEUT ... | Cashman Christopher Michael | PRESIDENT AND CEO | Buy | M | 1.04 | 17,608 | 18,312 | 98,438 | 80.8 K to 98.4 K (+21.78 %) |
Jan 07 2015 | MRNS | MARINUS PHARMACEUT ... | Patroneva Albena | Chief Medical Offic ... | Option Exercise | A | 10.57 | 158,000 | 1,670,060 | 158,000 | |
Dec 23 2014 | MRNS | MARINUS PHARMACEUT ... | Farfel Gail M | Chief Clinical Dev ... | Option Exercise | A | 8.70 | 43,000 | 374,100 | 43,000 | |
Dec 23 2014 | MRNS | MARINUS PHARMACEUT ... | Cashman Christopher Michael | President and CEO | Option Exercise | A | 8.70 | 275,000 | 2,392,500 | 275,000 | |
Dec 23 2014 | MRNS | MARINUS PHARMACEUT ... | Smith Edward F | CFO | Option Exercise | A | 8.70 | 62,000 | 539,400 | 62,000 | |
Oct 02 2014 | MRNS | MARINUS PHARMACEUT ... | Canaan VII LP | Director | Option Exercise | A | 6.47 | 6,000 | 38,820 | 6,000 | |
Oct 09 2014 | MRNS | MARINUS PHARMACEUT ... | Cashman Christopher Michael | PRESIDENT AND CEO | Option Exercise | M | 1.04 | 80,830 | 84,063 | 88,040 | |
Oct 09 2014 | MRNS | MARINUS PHARMACEUT ... | Cashman Christopher Michael | PRESIDENT AND CEO | Buy | M | 1.04 | 80,830 | 84,063 | 80,830 | 0 to 80.8 K |
Oct 02 2014 | MRNS | MARINUS PHARMACEUT ... | Bloch Stephen M | Director | Option Exercise | A | 6.47 | 6,000 | 38,820 | 6,000 | |
Oct 02 2014 | MRNS | MARINUS PHARMACEUT ... | Gopka Anton | Director | Option Exercise | A | 6.47 | 6,000 | 38,820 | 6,000 | |
Oct 02 2014 | MRNS | MARINUS PHARMACEUT ... | Carrazana Enrique J. | Director | Option Exercise | A | 6.47 | 6,000 | 38,820 | 6,000 | |
Oct 02 2014 | MRNS | MARINUS PHARMACEUT ... | MAYLEBEN TIMOTHY M | Director | Option Exercise | A | 6.47 | 6,000 | 38,820 | 6,000 |